HomeCompareGLPEF vs MRK

GLPEF vs MRK: Dividend Comparison 2026

GLPEF yields 3.12% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GLPEF wins by $15.4K in total portfolio value· pulled ahead in Year 5
10 years
GLPEF
GLPEF
● Live price
3.12%
Share price
$24.00
Annual div
$0.75
5Y div CAGR
35.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.2K
Annual income
$17,928.83
Full GLPEF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GLPEF vs MRK

📍 GLPEF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGLPEFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GLPEF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GLPEF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLPEF
Annual income on $10K today (after 15% tax)
$264.99/yr
After 10yr DRIP, annual income (after tax)
$15,239.51/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GLPEF beats the other by $6,911.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLPEF + MRK for your $10,000?

GLPEF: 50%MRK: 50%
100% MRK50/50100% GLPEF
Portfolio after 10yr
$64.5K
Annual income
$13,863.48/yr
Blended yield
21.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GLPEF
No analyst data
Altman Z
3.2
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLPEF buys
0
MRK buys
0
No recent congressional trades found for GLPEF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGLPEFMRK
Forward yield3.12%2.76%
Annual dividend / share$0.75$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.5%32.7%
Portfolio after 10y$72.2K$56.8K
Annual income after 10y$17,928.83$9,798.13
Total dividends collected$46.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GLPEF vs MRK ($10,000, DRIP)

YearGLPEF PortfolioGLPEF Income/yrMRK PortfolioMRK Income/yrGap
1$11,122$422.42$11,206$366.19$84.00MRK
2$12,496$594.98$12,650$502.35$154.00MRK
3$14,217$846.50$14,407$694.19$190.00MRK
4$16,432$1,219.62$16,585$967.82$153.00MRK
5← crossover$19,367$1,785.08$19,342$1,363.89+$25.00GLPEF
6$23,387$2,664.36$22,913$1,947.19+$474.00GLPEF
7$29,099$4,074.38$27,662$2,823.89+$1.4KGLPEF
8$37,555$6,419.65$34,159$4,173.35+$3.4KGLPEF
9$50,676$10,492.12$43,337$6,308.80+$7.3KGLPEF
10$72,153$17,928.83$56,776$9,798.13+$15.4KGLPEF

GLPEF vs MRK: Complete Analysis 2026

GLPEFStock

Galp Energia, SGPS, S.A. operates as an integrated energy operator in Portugal and internationally. The company operates through four segments: Upstream, Industrial & Energy Management, Commercial, and Renewables and New Business. The Upstream segment engages in the exploration, development, and production of hydrocarbons primarily in Brazil, Mozambique, and Angola. The Industrial & Energy Management segment owns refineries in Portugal, as well as is involved in activities related to energy management of oil products, gas, and electricity. This segment also provides storage and transportation infrastructure for oil and gas products, as well as engages in the sale of electricity to the grid in Portugal and Spain. The Commercial segment is involved in the areas of retail to final business-to-business and business to consumer customers of oil, gas, and electricity. The Renewables and New Business segment is involved in the development of solar and wind power generation projects in Portugal and Spain. In addition, it produces biodiesel, biofuel, and green hydrogen; and operates 1,480 service stations and 1,186 electric mobility charging points. Further, the company engages in the reinsurance business. The company was formerly known as Galp – Petróleos e Gás de Portugal, SGPS, S.A. and changed its name to Galp Energia, SGPS, S.A. in September 2000. Galp Energia, SGPS, S.A. was incorporated in 1999 and is headquartered in Lisbon, Portugal.

Full GLPEF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GLPEF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLPEF vs SCHDGLPEF vs JEPIGLPEF vs OGLPEF vs KOGLPEF vs MAINGLPEF vs JNJGLPEF vs ABBVGLPEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.